Amgen to Present at the Barclays Capital Global Healthcare Conference
March 09 2009 - 8:11PM
PR Newswire (US)
THOUSAND OAKS, Calif., March 9 /PRNewswire-FirstCall/ -- Amgen
(NASDAQ: AMGN) will present at the Barclays Capital Global
Healthcare Conference on Wednesday, March 11, 2009 at the Loews
Miami Beach Hotel, Miami Beach, Fla., beginning at 9:00 a.m.
Eastern Time. Amgen's Chief Financial Officer Robert A. Bradway
will present. Live audio of the presentation will be available over
the Internet and can be accessed from Amgen's Web site,
http://www.amgen.com/, under Investors. Information regarding
presentation time, webcast availability, and webcast links are
available on Amgen's Investor Relations Events Calendar. About
Amgen Amgen discovers, develops, manufactures and delivers
innovative human therapeutics. A biotechnology pioneer since 1980,
Amgen was one of the first companies to realize the new science's
promise by bringing safe and effective medicines from lab, to
manufacturing plant, to patient. Amgen therapeutics have changed
the practice of medicine, helping millions of people around the
world in the fight against cancer, kidney disease, rheumatoid
arthritis, and other serious illnesses. With a deep and broad
pipeline of potential new medicines, Amgen remains committed to
advancing science to dramatically improve people's lives. To learn
more about our pioneering science and our vital medicines, visit
http://www.amgen.com/. CONTACT: Amgen, Thousand Oaks David Polk,
805-447-4613 (media) Justin Claeys, 805-447-1060 (investors) (Logo:
http://www.newscom.com/cgi-bin/prnh/20081015/AMGENLOGO)
http://www.newscom.com/cgi-bin/prnh/20081015/AMGENLOGO
http://photoarchive.ap.org/ DATASOURCE: Amgen CONTACT: Media, David
Polk, +1-805-447-4613, or Investors, Justin Claeys,
+1-805-447-1060, both of Amgen Web Site: http://www.amgen.com/
Copyright